These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 14671961)
1. [Question 4. What diagnostic and therapeutic strategies in glucose metabolism disorders in the course of cystic fibrosis? Diabetes and cystic fibrosis: physiopathology and diagnostic criteria for glucose metabolism disorders]. Mosnier-Pudar H Arch Pediatr; 2003 Aug; 10 Suppl 3():462s-468s. PubMed ID: 14671961 [No Abstract] [Full Text] [Related]
2. [Question 4. What diagnostic and therapeutic strategies in glucose metabolism disorders in cystic fibrosis? Therapeutic strategy in glucose metabolism disorders on cystic fibrosis]. Martin C Arch Pediatr; 2003 Aug; 10 Suppl 3():469s-474s. PubMed ID: 14671962 [No Abstract] [Full Text] [Related]
3. Update on cystic fibrosis-related diabetes. Kelly A; Moran A J Cyst Fibros; 2013 Jul; 12(4):318-31. PubMed ID: 23562217 [TBL] [Abstract][Full Text] [Related]
4. [Question 4. Diagnostic and therapeutic strategies in glucose metabolism disorders in the course of cystic fibrosis]. Bretones P Arch Pediatr; 2003 Aug; 10 Suppl 3():475s-486s. PubMed ID: 14671963 [No Abstract] [Full Text] [Related]
5. Diagnosis, screening, and management of cystic fibrosis-related diabetes. Moran A Curr Diab Rep; 2002 Apr; 2(2):111-5. PubMed ID: 12643130 [TBL] [Abstract][Full Text] [Related]
6. Not your type? Wahowiak L Diabetes Forecast; 2014 May; 67(5):52-5. PubMed ID: 24851499 [No Abstract] [Full Text] [Related]
7. The use of insulin in cystic fibrosis-related diabetes: a philosophical difference from the use of insulin in type 1 and type 2 diabetes. Bremer AA Pediatr Pulmonol; 2012 Nov; 47(11):1039-41. PubMed ID: 22911489 [No Abstract] [Full Text] [Related]
8. Cystic fibrosis-related diabetes compared with type 1 and type 2 diabetes in adults. Konrad K; Scheuing N; Badenhoop K; Borkenstein MH; Gohlke B; Schöfl C; Seufert J; Thon A; Holl RW Diabetes Metab Res Rev; 2013 Oct; 29(7):568-75. PubMed ID: 23704008 [TBL] [Abstract][Full Text] [Related]
9. Accuracy of administrative coding for type 2 diabetes in children, adolescents, and young adults. Rhodes ET; Laffel LM; Gonzalez TV; Ludwig DS Diabetes Care; 2007 Jan; 30(1):141-3. PubMed ID: 17192348 [No Abstract] [Full Text] [Related]
10. The patient with newly diagnosed diabetes mellitus. Fulcher G; Carter J Aust Fam Physician; 1990 Aug; 19(8):1225-9, 1232-4. PubMed ID: 2206116 [TBL] [Abstract][Full Text] [Related]
12. Use of continuous subcutaneous insulin infusion in cystic fibrosis patients with cystic fibrosis-related diabetes awaiting transplantation. Reali MF; Festini F; Neri AS; Taccetti G; Repetto T; Chiarelli F; Toni S J Cyst Fibros; 2006 Jan; 5(1):67-8. PubMed ID: 16233992 [No Abstract] [Full Text] [Related]
13. Abnormal glucose tolerance in CF--when should we offer diabetes treatment? Moran A Pediatr Diabetes; 2009 May; 10(3):159-61. PubMed ID: 19422601 [No Abstract] [Full Text] [Related]
14. Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis. Cano Megías M; González Albarrán O; Guisado Vasco P; Lamas Ferreiro A; Máiz Carro L Endocrinol Nutr; 2015 Feb; 62(2):91-9. PubMed ID: 25444978 [TBL] [Abstract][Full Text] [Related]
15. Can glargine reduce the number of lung infections in patients with cystic fibrosis-related diabetes? Franzese A; Spagnuolo MI; Sepe A; Valerio G; Mozzillo E; Raia V Diabetes Care; 2005 Sep; 28(9):2333. PubMed ID: 16123520 [No Abstract] [Full Text] [Related]